InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,469.30
(
0.00%
)
US TECH 100
19,156.00
(
-0.10%
)
Dow Jones
39,112.16
(
0.00%
)
Brent Oil
84.63
(
0.52%
)
Bitcoin
61,387.83
(
-0.69%
)
Post# of 7536
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

kei

Send PM Follow Ignore
Followers 306
Posts 22916
Boards Moderated 0
Alias Born 10/10/2007

kei

Re: porgyrusty post# 6129

Monday, 02/26/2018 7:01:19 AM

Monday, February 26, 2018 7:01:19 AM

Post# of 7536
from biopharmacatalyst - RIGL Fostamatinib $3.73
Phase 3 data from the first trial released August 30 2016. Primary endpoint met. Data from second trial did not meet the primary endpoint. PDUFA date April 17, 2018. Noted October 2, 2017 that no Advisory Committee meeting is planned.

°°° (\__/) (\_(\ ° ° °
°°° (='.'=) (=' :') °°°
°°° (")_(") (,(')(')°°°
°°° °°° °°° °°° °°°


Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up